TEX13B

Across TCGA pan-cancer cohorts, TEX13B RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of TEX13B’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where TEX13B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TEX13B is over-expressed in tumor.

KIRC, HNSC, and LUSC are the cancer types where TEX13B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TEX13B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.028	.001	9	view →
HNSC	Male	All	+0.040	<.001	6	view →
LUSC	Male	All	+0.080	<.001	5	view →
BRCA	All	All	+0.040	.010	4	view →
COAD	All	All	+0.027	.007	2	view →
LUAD	All	All	+0.027	.032	1	view →
THCA	All	II,III,IV	+0.019	.029	1	view →
LIHC	All	All	+0.006	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

TEX13B–KIRC

Open the KIRC breakdown →